Hot flush: FDA reporting patterns
74,388 FDA FAERS reports mention Hot flush. 29,138 reports have a serious outcome flag.
Medicines named as suspect
- Leuprolide: 10,925 reports
- Relugolix: 7,459 reports
- Estradiol: 4,030 reports
- Enzalutamide: 3,282 reports
- Dimethyl Fumarate: 2,569 reports
- Palbociclib: 1,897 reports
- Adalimumab: 1,507 reports
- Levothyroxine: 1,340 reports
- Niacin: 1,314 reports
- Anastrozole: 1,229 reports
- Estrogens Conjugated: 1,204 reports
- Letrozole: 1,180 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.